CVS is working with advisors on strategic review, sources say

CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter.
The review has been ongoing for some time, said the people, but there is no certainty on what actions, if any, the company will take.

CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter, as the company contends with potential activist pressure and a severely depressed stock price.

STAY IN THE KNOW

	Watch NBC10 Boston news for free, 24/7, wherever you are.
	Get Boston local news, weather forecasts, lifestyle and entertainment stories to your inbox. Sign up for NBC Boston’s newsletters.

The review has been ongoing for some time, said the people, but there is no certainty on what actions, if any, the company will take.

CVS management, including CEO Karen Lynch, met with major shareholder Glenview Capital Monday to discuss the company's lagging prospects and Glenview's plans to revive the stock, CNBC previously reported.

Get top local stories in Boston delivered to you every morning. Sign up for NBC Boston's News Headlines newsletter.

But Lynch has to contend with an insurance business hammered by heightened medical costs.

In a statement, CVS spokesman David Whitrap told CNBC: "CVS Health's management team and Board of Directors are continually exploring ways to create shareholder value. We remain focused on driving performance and delivering high quality healthcare products and services enabled by our unmatched scale and integrated model."

The company has also grappled with leadership turnover. Lynch assumed direct leadership of CVS's insurance unit earlier this year, displacing then-president Brian Kane.